SoftBank China Venture Capital and Legend Capital contributed to a round that boosted the cancer screening device maker's overall funding to more than $100m.

China-based cancer screening product developer New Horizon Health has received $66m in a series C round that included SoftBank China Venture Capital (SBCVC), a subsidiary of telecommunications and internet group SoftBank, ChuangJianHui has reported. Legend Capital, the venture capital firm established by conglomerate Legend Holdings, also participated in the round, which was led by private…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.